Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-25

Clinical Trial Update: Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function

View source ↗

Summary

A completed clinical trial update evaluating whether the risk of linezolid-induced thrombocytopenia differs between patients with normal renal function and thos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Linezolid)

Snippet

Sponsor: Ain Shams University | Conditions: Thrombocytopaenia, Impaired Renal Function | Status: COMPLETED